---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-091581"
form_type: "8-K"
ticker: "APVO"
cik: "0001671584"
company_name: "Aptevo Therapeutics Inc."
filed_at: "2025-06-30T23:59:59+00:00"
generated_at: "2026-05-18T13:21:31.994135+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Aptevo raises $15.9M in Q2 equity offerings, believes it regains Nasdaq compliance on stockholders' equity

## Summary
- Raised approx. $15.9M via four equity transactions: April 4 ($2.1M), April 22 ($2.0M), June 20 ($8.0M), and ATM facility ($3.8M).
- Company believes stockholders' equity now exceeds the $2.5M minimum required by Nasdaq Listing Rule 5550(b)(1).
- Awaiting formal confirmation from Nasdaq of compliance; previously disclosed deficiency for quarter ended March 31, 2025.

## SEC filing metadata
- accession: 0000950170-25-091581
- form_type: 8-K
- ticker: APVO
- cik: 0001671584
- company_name: Aptevo Therapeutics Inc.
- filed_at: 2025-06-30T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671584/000095017025091581/0000950170-25-091581-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671584/000095017025091581/apvo-20250630.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-091581
- JSON: https://secwatch.observer/filing/0000950170-25-091581.json
- Plain text: https://secwatch.observer/filing/0000950170-25-091581.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.